MedTrace Logo

Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health

NCT04768244 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-10-25

No results posted yet for this study

Summary

prospective multicenter study The main aim is to study the impact of maternal COVID-19 on breast milk immune, microbiological, and metabolic profile and infant growth and development

Conditions

  • Covid19

Interventions

OTHER

maternal SARS-CoV-2 infection

positive PCR in nasopharinx and/or presence of antibodies in serum

Sponsors & Collaborators

  • Hospital Universitario La Fe

    collaborator OTHER

  • Instituto de Investigacion Sanitaria INCLIVA

    collaborator INDUSTRY

  • Hospital Clínico Universitario de Valencia

    collaborator OTHER

  • Hospital Universitario Doctor Peset

    collaborator OTHER

  • Universidad de Granada

    collaborator OTHER

  • Universitat Jaume I

    collaborator OTHER

  • Hospital Sant Joan de Deu

    collaborator OTHER

  • Fetal Medicine Research Center, Spain

    collaborator OTHER

  • Instituto de Investigación Sanitaria Aragón

    collaborator OTHER

  • Institute of Agrochemistry and Food Technology, National Research Council

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2023-03-31
Completion
2023-10-10

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04768244 on ClinicalTrials.gov